Delivery Order SPE2DB22D2218-SPE2DB24FR2XK
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $3,002.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 20, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3ml, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,801.80, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 4, 2024. The contract is a firm fixed-price, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,417.47, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $1,741.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 29, 2024. This is a delivery order placed against Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The $6,244.06 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 25, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $26,440.20, was made by the Defense Logistics Agency (DLA), a defense agency, under a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of November 1, 2024. This award is not designated as a set-aside contract. The contract represents a...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,120.99 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a...
The federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3ml pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $10,893.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 12, 2025, with a completion date of June 13, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $2,004.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024 with a completion date of September 25, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,940.83, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 7, 2024, with an ultimate completion date of October 8, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...